Published in Neurochem Int on November 13, 2011
Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. J Clin Exp Hepatol (2014) 0.91
Pathophysiology of cerebral oedema in acute liver failure. World J Gastroenterol (2013) 0.87
TIMP-1 attenuates blood-brain barrier permeability in mice with acute liver failure. J Cereb Blood Flow Metab (2013) 0.85
Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug delivery. J Investig Med (2012) 0.82
Morphological changes of cortical pyramidal neurons in hepatic encephalopathy. BMC Neurosci (2014) 0.81
Alterations of blood-brain barrier and associated factors in acute liver failure. Gastroenterol Res Pract (2013) 0.76
Unconjugated bilirubin elevation impairs the function and expression of breast cancer resistance protein (BCRP) at the blood-brain barrier in bile duct-ligated rats. Acta Pharmacol Sin (2016) 0.75
Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking. Tissue Barriers (2015) 0.75
To Break or to Brake Neuronal Network Accelerated by Ammonium Ions? PLoS One (2015) 0.75
Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure. J Virol (2016) 0.75
Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol (1993) 10.65
Structure and function of the blood-brain barrier. Neurobiol Dis (2009) 7.64
The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev (2005) 7.56
Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol (2003) 5.74
Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab (2006) 4.19
Presidental address. Neuropathological aspects of brain edema. J Neuropathol Exp Neurol (1967) 4.06
A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol (1997) 3.86
Acute liver failure: Summary of a workshop. Hepatology (2008) 3.49
Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis (2008) 3.40
The blood-brain barrier to proteins under normal and pathological conditions. J Neurol Sci (1970) 3.18
Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab (2000) 3.04
Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke (1998) 3.03
Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol (2005) 2.92
Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology (2006) 2.62
Acute liver failure in the United States. Semin Liver Dis (2003) 2.39
Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology (2007) 2.32
Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci (2000) 2.18
Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest (2005) 1.92
Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res (2001) 1.90
Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology (2009) 1.87
Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg (1993) 1.83
Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat Med (2001) 1.81
Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg Focus (2007) 1.78
Tumour necrosis factor-alpha affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure. Liver Int (2010) 1.72
Multiple domains of occludin are involved in the regulation of paracellular permeability. J Cell Biochem (2000) 1.65
Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia (2006) 1.58
Alterations in expression of genes coding for proteins of the neurovascular unit in ischemic liver failure. Neurochem Int (2009) 1.55
Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuroreport (2001) 1.53
Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view. Brain Res Brain Res Rev (2003) 1.44
Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis (2010) 1.31
Hepatic encephalopathy and cerebral edema. Semin Liver Dis (1986) 1.28
Water homeostasis in the brain: basic concepts. Neuroscience (2004) 1.28
Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology (2011) 1.27
Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice. J Hepatol (2005) 1.21
A dominant mutant of occludin disrupts tight junction structure and function. J Cell Sci (1999) 1.18
Changes in the blood-brain barrier in hepatic coma after hepatectomy in the rat. Gastroenterology (1977) 1.14
Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Semin Liver Dis (1986) 1.11
Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology (1992) 1.10
Differential permeability of cerebral capillary and choroid plexus to lanthanum ion. Brain Res (1975) 1.09
Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline. J Neurochem (2009) 1.08
Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia. J Cereb Blood Flow Metab (2009) 1.06
Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology (2007) 1.03
Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: ultrastructure and integrity of the blood-brain barrier. Hepatology (1988) 1.01
IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure. Neurochem Int (2009) 1.01
N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms. Metab Brain Dis (2010) 1.00
Emergency adult-to-adult living-donor liver transplantation for acute liver failure in a hepatitis B virus endemic area. Hepatology (2010) 0.99
RNAi-mediated reversible opening of the blood-brain barrier. J Gene Med (2008) 0.98
Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int (2004) 0.97
Regional cerebral edema and chloride space in galactosamine-induced liver failure in rats. Hepatology (1997) 0.96
Enhancement of drug absorption through the blood-brain barrier and inhibition of intercellular tight junction resealing by E-cadherin peptides. Mol Pharm (2010) 0.95
Increased blood-brain transfer in a rabbit model of acute liver failure. Gastroenterology (1983) 0.95
Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems. ASAIO Trans (1990) 0.94
Targeted and reversible disruption of the blood-testis barrier by an FSH mutant-occludin peptide conjugate. FASEB J (2006) 0.94
Brain region-selective mechanisms contribute to the progression of cerebral alterations in acute liver failure in rats. Gastroenterology (2010) 0.93
Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension. Metab Brain Dis (2007) 0.93
Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7. Brain Res (1995) 0.91
Reuse of liver graft from a brain dead recipient. Clin Transplant (2007) 0.91
Long-term outcomes of emergency liver transplantation for acute liver failure. Liver Transpl (2009) 0.91
Late reuse of liver allografts from brain-dead graft recipients: the Munich experience and a review of the literature. Liver Transpl (2010) 0.91
Rescue hepatectomy for initial graft non-function after liver transplantation. Transplantation (1999) 0.90
Successful reuse of liver grafts after death of the first recipient. Clin Transplant (2006) 0.90
Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy. Ann Hepatol (2004) 0.89
Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control study. Ann Surg (2001) 0.89
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver Transpl (2006) 0.88
Altered expression of zonula occludens-2 precedes increased blood-brain barrier permeability in a murine model of fulminant hepatic failure. J Invest Surg (2008) 0.88
Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging. J Magn Reson Imaging (2008) 0.88
TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure. J Surg Res (2006) 0.88
Reuse of a liver graft five days after initial transplantation. Transplantation (1996) 0.88
13N as a tracer for studying glutamate metabolism. Neurochem Int (2010) 0.87
Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci Lett (1997) 0.87
Occludin is regulated by epidermal growth factor receptor activation in brain endothelial cells and brains of mice with acute liver failure. Hepatology (2011) 0.86
Diffusion tensor imaging supports the cytotoxic origin of brain edema in a rat model of acute liver failure. Gastroenterology (2009) 0.86
Brain edema in acute liver failure: can it be prevented? Can it be treated? J Hepatol (2007) 0.84
Alterations in expression of genes coding for key astrocytic proteins in acute liver failure. J Neurosci Res (2001) 0.84
Size-selective junctional barrier and Ca(2+)-independent cell adhesion in the testis of Cynops pyrrhogaster: expression and function of occludin. Mol Reprod Dev (2008) 0.83
Role of aquaporin-4 in the development of brain oedema in liver failure. J Hepatol (2010) 0.83
Brain aquaporin-4 in experimental acute liver failure. J Neuropathol Exp Neurol (2010) 0.82
Pathogenesis of brain edema in fulminant hepatic failure. Prog Liver Dis (1995) 0.82
Selectively increased expression of the astrocytic/endothelial glucose transporter protein GLUT1 in acute liver failure. Glia (2006) 0.82
Intracranial hypertension in acute liver failure: pathophysiological basis of rational management. Semin Liver Dis (2003) 0.81
Neuropathological changes in the brain of pigs with acute liver failure. Scand J Gastroenterol (2010) 0.79
Acute liver failure. Br J Hosp Med (1979) 0.79
Brain expression of the water channels aquaporin-1 and -4 in mice with acute liver injury, hyperammonemia and brain edema. Metab Brain Dis (2010) 0.79
Bilateral decompressive craniectomy due to intracranial hypertension during acute posttraumatic liver dysfunction. J Trauma (2005) 0.76